1. 207 POLE proofreading mutations elicit an anti-tumor immune response in endometrial cancer. (September 2015) Authors: Van Gool, I.; Eggink, F.; Freeman-Mills, L.; Stelloo, E.; Marchi, E.; Palles, C.; De Bruyn, M.; Nout, R.; De Kroon, C.; Osse, M.; Klenerman, P.; Creutzberg, C.; Tomlinson, I.; Smit, V.; Nijman, H.; Bosse, T.; Church, D. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Practical guidance for mismatch repair-deficiency testing in endometrial cancer. (13th October 2016) Authors: Stelloo, E.; Jansen, A. M. L.; Osse, E. M.; Nout, R. A.; Creutzberg, C. L.; Ruano, D.; Church, D. N.; Morreau, H.; Smit, V. T. H. B. M.; van Wezel, T.; Bosse, T. Journal: Annals of oncology Issue: Volume 28:Number 1(2017) Page Start: 96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy. Issue 9 (30th October 2018) Authors: Wortman, B.; Creutzberg, C.; Putter, H.; Jürgenliemk-Schulz, I.; Jobsen, J.; Lutgens, L.; Steen-Banasik, E.; Mens, J.; Slot, A.; Kroese, M.; Triest, B.; Nijman, H.; Stelloo, E.; Bosse, T.; Boer, S.; Putten, W.; Smit, V.; Nout, R. Journal: British journal of cancer Issue: Volume 119:Issue 9(2018) Page Start: 1067 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗